FDA

FDA elevates thyroid tablet recall to most serious level

Will FDA advisers recommend a multi-cancer blood test for approval? They'll vote

Otsuka heads to FDA as Ionis-partnered ALS drug hits primary phase 3 endpoint

Grail Catapults 30%-Plus As FDA Mulls Cancer-Detecting Blood Test

Experts urge FDA to set clear safety and access standards for psychedelic drugs

FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly

The FDA has granted clearance to a new Alzheimer’s disease blood test developed by Roche and Eli Lilly.

Marketside soup sold at Walmart recalled over Listeria concerns: FDA

Marketside tomato bisque soup kits face a 29‑state recall over potential Listeria, hitting Walmart shoppers nationwide

FDA approves 1st mRNA flu shot, from Moderna

The first mRNA-based influenza vaccine has received federal approval in the United States.

The FDA Issued a Recall on Thyroid Medication Nationwide

The FDA has issued a nationwide recall of levothyroxine sodium tablets due to the drug being described as subpotent.

FDA staff flags data concerns about Capricor's therapy; shares plunge

Capricor Therapeutics shares are plummeting after FDA staff disputed the company's claims of Phase 3 success for its DMD cell therapy.

Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug

Capricor Therapeutics shares have plunged after FDA staff raised concerns regarding the efficacy and data of its Duchenne heart disease therapy.

Compounded GLP-1 drugs creating concern among doctors and FDA

Compounded GLP-1 weight‑loss drugs face mounting scrutiny as doctors and regulators flag safety concerns.

Cyclospora outbreak has many changing eating habits, CBS News poll finds; mixed and partisan confidence in FDA

A July 2026 Cyclospora scare is reshaping menus, boosting local produce sales and testing public trust in the FDA.

Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide

Eli Lilly is planning a Q1 2027 FDA application for retatrutide following new data on weight loss and A1C improvements.

FDA recalls 180,000 cans of soup sold at Walmart - the-sun.com

Amy’s Kitchen has recalled over 184,000 cans of vegan lentil soup across the U.S. due to a can defect that poses a spoilage risk.

Trump Live Updates: FDA Peptide Meetings, Tariffs and Latest News

FDA advisory committees have issued split decisions on the legal path for peptides amid high-profile advocacy for their wider availability.

The Great Peptide Cash Grab Has Begun

An FDA advisory panel review of seven peptides is sparking a debate over longevity medicine, public health risks, and potential multibillion-dollar markets.

How to tell if your lettuce is safe to eat during cyclospora outbreak

Federal health officials investigate multiple clusters of cyclosporiasis, with iceberg lettuce identified as the likely cause.

FDA still focused on Taylor Farms lettuce as Cyclospora source despite retracted test

The FDA continues to target Taylor Farms lettuce as the source of a Cyclospora outbreak despite a retracted positive test result.

Explosive diarrhea outbreak: Lettuce tests positive for cyclospora, FDA says

A multi-state iceberg lettuce recall is underway after the FDA linked a cyclosporis parasite outbreak to Taylor Farms.

Pillsbury recalls 2 bread products over potential glass contamination

General Mills is recalling 730,000 Pillsbury bread rolls across 18 states due to potential glass contamination.

Iceberg lettuce sold at Taco Bell linked to cyclospora outbreak

A multistate cyclospora parasite outbreak has been linked to iceberg lettuce supplied by Taylor Farms to Taco Bell stores.

Lettuce supplier is potential source of cyclosporiasis outbreak, investigators say

Taco Bell has removed lettuce from its U.S. menus following links to a cyclosporiasis outbreak traced to supplier Taylor Farms.

The F.D.A. Approves a New Pill to Slash Cholesterol Levels

The FDA has approved Lipfendra, the first-of-its-kind oral PCSK9 inhibitor designed to significantly reduce cholesterol levels.

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector

Sanofi's Sarclisa becomes the first cancer drug approved by the FDA for delivery via an on-body injector for multiple myeloma.

FDA recalls eye drops over possible 'foreign substance'

The FDA has issued a nationwide recall of 2.5 million bottles of steroid eye drops due to contamination concerns.

FDA approves Vera Therapeutics kidney disease treatment

The FDA has approved Vera Therapeutics' drug Trutakna to treat primary IgA nephropathy, sparking a new market competition for kidney disease treatments.

The New Rules of Sunscreen

The U.S. sunscreen market is shifting toward clinical necessity following the FDA's first approval of a new active ingredient in decades.

Potato chip recall upgraded to highest FDA risk level over salmonella concerns

The FDA has upgraded a potato chip recall involving brands like Utz Zapp's and Dirty to Class I, its highest risk level, due to salmonella concerns.

Exclusive: FDA allows ZYN to sell pouches on health benefits

The FDA has granted Philip Morris permission to market ZYN nicotine pouches as a safer, lower-risk alternative to cigarettes.

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

The FDA has launched a new initiative to accelerate the review process for new pharmaceutical manufacturing facilities.

Supplements sold online through major retailers recalled nationwide over potential salmonella risk

Major online retailers are recalling TNVitamins moringa powder supplements nationwide due to potential salmonella contamination.

Potato chip recall upgraded to highest FDA risk level over salmonella concerns

The FDA has classified a massive recall of Utz potato chip brands as a Class I risk due to potential salmonella contamination.

New Drugs Are Replacing Chemo for Aggressive Breast Cancer

The FDA has granted broad first-line approval for Gilead's Trodelvy, signaling a shift away from traditional chemotherapy for aggressive breast cancer.

The Wearable Data Your Doctor Actually Wants

Wearable technology is shifting from general fitness tracking toward clinical healthcare integration and Medicare eligibility.

HHS Launches Unprecedented Department-Wide Effort to Restore American Leadership in Clinical Trials

The U.S. Department of Health and Human Services is launching a department-wide effort to accelerate clinical trials and restore American leadership in medical research.